Insider Transactions Reported by 15 Insiders of PharmaCyte Biotech, Inc.

Symbol
PMCB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Laguna Hills, CA

There are no Buy or Sell transactions made by insiders since 12/15/2024

PharmaCyte Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joshua Silverman CEO and President, Director $365K Dec 12, 2025
Jonathan Schechter Director $135K Apr 25, 2025
Robert Weinstein Director $42.1K Apr 25, 2025
Michael M. Abecassis Director $23.4K Apr 25, 2025
Wayne R. Walker Director $21K Apr 25, 2025
Carlos Trujillo Chief Financial Officer, Director Nov 20, 2023
Matthias Loehr Director Mar 31, 2022
Daniel Stuart Farb Director Dec 28, 2022
Daniel Allen Director Dec 28, 2022
Gerald W. Crabtree Chief Science Officer, Director Aug 10, 2021
Yuen Thomas C K Director Aug 10, 2021
Jack E. Stover Director Aug 15, 2022
Thomas Liquard Director Aug 10, 2021
Kenneth L. Waggoner Chairman, CEO, Pres and GC, Director Aug 10, 2021
Raymond CF Tong Director Aug 10, 2021

Recent Insider Transactions by Companies or Individuals for PharmaCyte Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.